Caribou Biosciences Inc. (CRBU)
undefined
undefined%
At close: undefined
1.84
-2.90%
After-hours Dec 13, 2024, 07:51 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -102.07M -99.42M -66.92M -34.31M -23.43M
Depreciation & Amortization 3.52M 1.62M 984.00K 900.00K 751.00K
Stock-Based Compensation 13.75M 11.72M 3.45M 1.00M 1.23M
Other Working Capital -9.94M -2.43M 31.13M -1.07M -7.84M
Other Non-Cash Items -1.18M -584.00K 2.43M -1.79M -2.29M
Deferred Income Tax - -95.00K -1.52M 803.00K -
Change in Working Capital -7.32M -4.20M 29.07M 177.00K -8.27M
Operating Cash Flow -93.29M -90.97M -32.52M -33.22M -32.01M
Capital Expenditures -11.61M -7.05M -3.12M -1.31M -884.00K
Acquisitions - 600.00K - 10.00K -
Purchase of Investments -394.76M -339.06M -173.28M -10.00K -
Sales Maturities Of Investments 338.19M 252.87M - 7.67M 28.12M
Other Investing Acitivies - -600.00K -1.00M 10.00K 28.12M
Investing Cash Flow -68.18M -93.25M -176.40M 6.36M 27.23M
Debt Repayment - - 1.03M 1.47M -45.00K
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 1.58M 2.13M 111.38M 270.00K 217.00K
Financial Cash Flow 154.30M 2.13M 433.43M 1.74M 172.00K
Net Cash Flow -7.18M -182.08M 224.51M -25.12M -4.60M
Free Cash Flow -104.90M -98.02M -35.64M -34.53M -32.89M